Education
About Us
Working with TipRanks
Follow Us
Andreas Busch Insider Profile
4 Followers
Andreas Busch, CSO at Cyclerion Therapeutics, holds 327.26K shares in AbSci (Ticker: ABSI), holds 254.70K shares in Cyclerion Therapeutics (Ticker: CYCN). Most recently, Andreas Busch Bought ― shares of AbSci on Jul 29, 2025 for an estimated value of $152.00K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+23.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andreas Busch holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 19, 2019 - Nov 19, 2020
Return:+51.00%
The most profitable trade made by Andreas Busch
Andreas Busch's Trading History
Cyclerion Therapeutics
Nov 12, 2020
CSO
Uninformative Buy
316.25K
$599.83K
AbSci
Jul 29, 2025
Chief Innovation Officer
Informative Buy
152.00K
$958.88K
List of latest transactions for each holding click on a transaction to see Andreas Busch's performance on stock
You May Also Like
Andreas Busch insider profile FAQ
What is the percentage of profitable transactions made by Andreas Busch?
The percentage of profitable transactions made by Andreas Busch is 50%.
What is the average return per transaction made by Andreas Busch?
The average return per transaction made by Andreas Busch is 23.60%.
What stocks does Andreas Busch hold?
Andreas Busch holds: CYCN, ABSI stocks.
What was Andreas Busch’s latest transaction?
Andreas Busch latest transaction was an Informative Buy of $152.00K.
What was Andreas Busch's most profitable transaction?
Andreas Busch’s most profitable transaction was an Informative Buy of CYCN stock on November 19, 2019. The return on the trade was 51.00%.
What is Andreas Busch's role in Cyclerion Therapeutics?
Andreas Busch's role in Cyclerion Therapeutics is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.